Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.11M Buy
13,167
+584
+5% +$47.1K 0.05% 312
2026
Q1
$890K Sell
12,583
-1,207
-9% -$90.4K 0.04% 334
2025
Q4
$1.09M Buy
13,790
+2,249
+19% +$178K 0.05% 271
2025
Q3
$951K Buy
11,541
+1,384
+14% +$109K 0.05% 273
2025
Q2
$817K Buy
10,157
+527
+5% +$40.7K 0.05% 250
2025
Q1
$773K Sell
9,630
-809
-8% -$67.3K 0.06% 228
2024
Q4
$855K Buy
10,439
+1,062
+11% +$88.4K 0.08% 181
2024
Q3
$773K Buy
9,377
+59
+0.6% +$4.41K 0.07% 207
2024
Q2
$654K Buy
9,318
+194
+2% +$13.9K 0.06% 217
2024
Q1
$676K Buy
9,124
+275
+3% +$19.2K 0.06% 216
2023
Q4
$585K Buy
8,849
+3,986
+82% +$249K 0.06% 226
2023
Q3
$306K Buy
+4,863
New +$303K 0.04% 269

Other funds holding MET

Syon Capital's MET Position: Q2 2026 in Review

Syon Capital increased its MetLife (MET) stake by 4.6% in Q2 2026, buying an estimated $47.1K and bringing the position to 13,167 shares worth $1.11M. The position accounts for 0.05% of the portfolio, ranked #312.

Syon Capital first reported a position in MET in Q3 2023 and has held it in 12 quarters since. 1,449 funds tracked by Wall St. Rank hold MET as of Q2 2026.

  • Syon Capital held 13,167 shares of MetLife worth $1.11M as of Q2 2026.
  • Syon Capital bought 584 MetLife shares in Q2 2026, an estimated $47.1K.
  • MetLife made up 0.05% of Syon Capital's portfolio in Q2 2026, its #312 holding.
  • Syon Capital first reported a position in MetLife in Q3 2023 and has held it in 12 quarters since.
  • 1,449 funds tracked by Wall St. Rank held MetLife as of Q2 2026.

Based on Syon Capital's 13F filing for Q2 2026, filed 14 Aug 2026.